Definitive Contract W911NF16C0060
Award Date
4/27/16
Potential Completion Date
7/8/18
Potential Value
$1.7M
Funding Federal Agency
Defense Advanced Research Projects Agency
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Ceres Nanosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Manassas, VA 20110, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
Ceres Nanosciences, Inc. was awarded a definitive contract valued at $6.57 million by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to support the Rapid Acceleration of Diagnostics (RADx) initiative. The firm fixed price contract calls for Ceres Nanosciences to provide nanotrap particle manufacturing in Manassas, Virginia over a one year period ending August 2022. No subcontractors or set aside designations were identified. The RADx...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $78,048.30 firm fixed-price purchase order contract to Ceres Nanosciences, Inc., a for-profit organization based in Manassas, Virginia. The contract is for "Target-Capture Technology for Healthcare-Related Bacteria that are Prone to Carry Antimicrobial Resistant Genes." This award was not set aside. The contract has a period of performance through September 1, 2022. Ceres Nanosciences provides nanotechnology-enabled...
This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Nanosonic Inc., a private company specializing in advanced materials and devices. The $1,509,999.88 Firm Fixed Price contract was set aside for small businesses and is focused on research and development related to the Coronavirus COVID-19 national interest action. As a prime contractor, Nanosonic conducts research, prototypes, and provides products to DoD...
<p>This is a $149,500.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Nanomedical Diagnostics, Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES." The contract was awarded on October 24, 2016 with a final completion date of July 23, 2017.</p>
The Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute awarded Ceres Nanosciences, Inc. a $9.6 million firm fixed price definitive contract to develop a wastewater COVID-19 surveillance framework. Ceres will establish this framework, driven by public health authorities at the city, county and state levels, to meet their needs for monitoring SARS-CoV-2 in wastewater. Performance will take place in Manassas, Virginia over a period of...
This is a $224,995.00 STTR Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Brimrose Technology Corp, a for-profit company specializing in advanced material science and innovation. The contract is for the development of a multimodal non-destructive microfluidic sorting system for microbes, to support elemental analysis. This award was made under a DARPA Broad Agency Announcement seeking small business innovation in areas aligned with DARPA's mission, including...
The U.S. Department of Defense's Defense Advanced Research Projects Agency (DARPA) awarded a Small Business Innovation Research (SBIR) Phase I contract to Nano Terra, Inc., a self-certified small disadvantaged business, for $149,987.00. The contract is for a "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES". This is a firm-fixed-price, definitive contract with a period of performance ending on November 30, 2017. The contract was...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Xilis Inc., a for-profit manufacturing organization. The contract is for the development of tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens, with a total potential value of $224,658.00. The contract has a firm fixed price pricing type and a completion date of August 31, 2021. The original solicitation was a Broad...
This is a $223,201 firm fixed price STTR Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Netrias, LLC, a small business AI company. The contract is for the development of "PATHENGINE: A PLATFORM TO AUTOMATE THE INTEGRATION OF DATA TO PREDICT PATHOGENIC POTENTIAL", which aligns with DARPA's mission of advancing transformative technologies for national security. The contract was awarded under DARPA's Small Business Technology Transfer (STTR)...
This firm fixed price purchase order contract, awarded by the Centers for Disease Control and Prevention (CDC) to Nanocomposix, Inc., is for $150,000.00 and is for research and development under the Small Business Innovation Research (SBIR) program. The contract is not set aside for a specific business type. Nanocomposix is a small business that manufactures engineered nanoparticles and has previously performed prime contracts and subcontractor work for the National Institutes of Health, Food...